Explain this page
Arphra AIPlain-English read on Elanco Animal Health Incorporated’s valuation06-03today
- Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs1d
- Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs1d
- Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'11d
- New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience13d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$6.96
-71.25% vs spot
Recommendation
Sell
11 of 12 methods
Method spread
1bull9bear
±5% threshold
Analyst PT consensus: $28.40 (+17.26%)
Candlestick · 1Y
Open in chart workstation →ELAN
24.29-1.86%H 27.72L 19.40MA50 23.25MA200 —Avg vol 5.8M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.50% | +4.97% | +22.31% | +3.80% | +8.00% | +7.34% | +73.62% | +134.23% | -32.49% | -32.53% | -32.53% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$24.22
195 sh
Bid
$24.10
900 sh
Ask
$24.95
100 sh
Spread
$0.850
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $1.14B | -$276M | $-0.55 |
| Q3 Sep 2025 | $1.14B | -$34M | $-0.07 |
| Q2 Jun 2025 | $1.24B | $11M | $0.02 |
| Q1 Mar 2025 | $1.19B | $67M | $0.13 |
| Q4 Dec 2024 | $1.02B | -$8M | $-0.02 |
| Q3 Sep 2024 | $1.03B | $364M | $0.73 |
Sector & industry today
LiveSectors
- Industrials+0.92%
- Utilities+0.90%
- Basic Materials+0.55%
- Consumer Cyclical+0.52%
- Consumer Defensive+0.39%
- Energy+0.31%
- Financial Services-0.03%
- Real Estate-0.32%
- Healthcare-0.48%
- Technology-1.18%
- Communication Services-1.32%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.64%
- Electronic Gaming & Multimedia+5.05%
- Broadcasting-3.56%
- Communication Equipment-3.29%
- Independent Power Producers+3.15%
- Medical - Equipment & Services+3.05%
- Hardware, Equipment & Parts-2.64%
- Internet Content & Information-2.25%
- Conglomerates+2.20%
- Department Stores-2.03%
- Oil & Gas Energy+1.89%
- Construction Materials+1.88%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogsprnewswire.com·Jun 15, 2026
- Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogsprnewswire.com·Jun 15, 2026
- Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'youtube.com·Jun 04, 2026
- New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilienceprnewswire.com·Jun 03, 2026
- New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilienceprnewswire.com·Jun 03, 2026
- Elanco Animal Health Reports First Quarter 2026 Resultsprnewswire.com·May 06, 2026
Peers
No peer list available for ELAN.
Total assets
$13.36B
Total debt
$4.02B
Cash & equiv
$545M
Operating CF
$560M
Free cash flow
$284M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $4.72B | $252M | -$232M | $-0.47 | -4.92% |
| FY 2024 | $4.44B | $251M | $338M | $0.68 | +7.61% |
| FY 2023 | $4.42B | $326M | -$1.23B | $-2.50 | -27.87% |
| FY 2022 | $4.41B | $384M | -$78M | $-0.15 | -1.77% |
| FY 2021 | $4.76B | $304M | -$483M | $-0.97 | -10.14% |